Treatment Modification in Human Immunodeficiency Virus–Infected Individuals Starting Combination Antiretroviral Therapy Between 2005 and 2008
Open Access
- 1 January 2010
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 170 (1) , 57-65
- https://doi.org/10.1001/archinternmed.2009.432
Abstract
Combination antiretroviral therapy (CART) has dramatically reduced human immunodeficiency virus (HIV)–related morbidity and mortality.1-3 Current guidelines recommend starting CART at earlier stages of HIV infection and continuing lifelong treatment.4-6 However, adverse drug reactions, drug-drug interactions, and comorbidities and socioeconomic barriers may influence the safety and efficacy of CART.Keywords
This publication has 0 references indexed in Scilit: